Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
FDA Greenlights Formycon and Klinge’s Biosimilar to Eylea
Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Administration’s (FDA) approval of FYB203/AHZANTIVE®, a biosimilar to Eylea®. FYB203/AHZANTIVE® has been approved by the FDA for the treatment of patients with Age-Related Neovascular (wet)…
Beacon Therapeutics Propels Gene Therapy with $170M Funding
Beacon Therapeutics has successfully raised $170 million in Series B funding, marking a significant step forward in advancing its portfolio of ophthalmic gene therapies. The funds are earmarked to support the ongoing clinical development of Beacon’s lead candidate, AGTC-501, designed…
Study Suggests Novel Treatment Approach for Wet AMD
A recent study conducted on mice has provided promising insights into a potential alternative treatment for the “wet” version of age-related macular degeneration (AMD). Researchers identified an enzyme, telomerase, which plays a critical role in the abnormal blood vessel growth…
Alcon Finalizes Acquisition of BELKIN Vision
Alcon has finalized its acquisition of BELKIN Vision, marking a significant expansion of its glaucoma treatment offerings. The acquisition, valued at $81M upfront, with potential additional payments up to $385M contingent on sales milestones, includes BELKIN Vision’s innovative Direct Selective…
Roche’s Vabysmo Receives CHMP Recommendation for RVO
Roche announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the extension of marketing authorization for Vabysmo (faricimab). This recommendation includes the treatment of visual impairment…
What Is Symblepharon? | OBN
What Is Symblepharon? Symblepharon is a medical condition characterized by the adhesion of the conjunctiva, the clear membrane that covers the white part of the eye and the inside of the eyelids, to the cornea, the clear front part of…
Top 10 Ophthalmologists Who Changed the Field
Ophthalmology, the branch of medicine that deals with the diagnosis and treatment of eye-related diseases and disorders, has made great strides in the past century. The following ten individuals are among the most influential and accomplished ophthalmologists in history, each…
CHMP Issues Negative Opinion on Syfovre for Geographic Atrophy
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) delivered a negative opinion on the marketing authorization application (MAA) for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan), intended for the treatment of geographic atrophy (GA). CHMP’s Assessment…
Researchers Awarded Grants to Advance Vision Restoration Efforts
Researchers at the Department of Ophthalmology, University of Colorado School of Medicine, have been granted nearly $4 million in R01 grants from the National Institutes of Health (NIH) to bolster their work at CellSight, the Ocular Stem Cell and Regeneration…
Antibiotics Help Prevent Infections in Cataract Patients
A recent study published in JAMA Ophthalmology has highlighted the effectiveness of selective intracameral antibiotics combined with 1% povidone iodine in reducing the incidence of postoperative endophthalmitis after cataract surgery. Led by Jeroen van Rooij, MD, from Rotterdam Eye Hospital,…